Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0CMLST
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-NaPi3b antibody-drug conjugate (Genentech/Roche)
|
|||||
| Synonyms |
Anti-NaPi3b antibody-drug conjugate (Genentech/Roche)
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
Platinum resistant ovarian cancer [ICD11:2C73]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Sodium-dependent phosphate transport protein 2B (SLC34A2)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.